Literature DB >> 24282287

LGR5 positivity defines stem-like cells in colorectal cancer.

Daniela Hirsch1, Nick Barker, Nicole McNeil, Yue Hu, Jordi Camps, Katherine McKinnon, Hans Clevers, Thomas Ried, Timo Gaiser.   

Abstract

Like normal colorectal epithelium, colorectal carcinomas (CRCs) are organized hierarchically and include populations of cells with stem-like properties. Leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5) is associated with these stem cells in normal colorectal epithelium; however, the precise function of LGR5 in CRC remains largely unknown. Here, we analyzed the functional and molecular consequences of short hairpin RNA-mediated silencing of LGR5 in CRC cell lines SW480 and HT-29. Additionally, we exposed Lgr5-EGFP-IRES-CreERT2 mice to azoxymethane/dextrane sodium sulfate (AOM/DSS), which induces inflammation-driven colon tumors. Tumors were then flow-sorted into fractions of epithelial cells that expressed high or low levels of Lgr5 and were molecularly characterized using gene expression profiling and array comparative genomic hybridization. Silencing of LGR5 in SW480 CRC cells resulted in a depletion of spheres but did not affect adherently growing cells. Spheres expressed higher levels of several stem cell-associated genes than adherent cells, including LGR5. Silencing of LGR5 reduced proliferation, migration and colony formation in vitro and tumorigenicity in vivo. In accordance with these results, NOTCH signaling was downregulated upon LGR5 silencing. In AOM/DSS-induced colon tumors, Lgr5 high cells showed higher levels of several stem cell-associated genes and higher Wnt signaling than Lgr5 low tumor cells and Lgr5 high normal colon cells. Array comparative genomic hybridization revealed no genomic imbalances in either tumor cell fraction. Our data elucidate mechanisms that define the role of LGR5 as a marker for stem-like cells in CRC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24282287      PMCID: PMC3977143          DOI: 10.1093/carcin/bgt377

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  49 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

3.  Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.

Authors:  Marian Grade; Patrick Hörmann; Sandra Becker; Amanda B Hummon; Danny Wangsa; Sudhir Varma; Richard Simon; Torsten Liersch; Heinz Becker; Michael J Difilippantonio; B Michael Ghadimi; Thomas Ried
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

5.  Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors.

Authors:  Terrill McClanahan; Sandra Koseoglu; Kathleen Smith; Jeffrey Grein; Eric Gustafson; Stuart Black; Paul Kirschmeier; Ahmed A Samatar
Journal:  Cancer Biol Ther       Date:  2006-04-19       Impact factor: 4.742

6.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

7.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression.

Authors:  Clemens Neufert; Christoph Becker; Markus F Neurath
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome.

Authors:  Jordi Camps; Marian Grade; Quang Tri Nguyen; Patrick Hörmann; Sandra Becker; Amanda B Hummon; Virginia Rodriguez; Settara Chandrasekharappa; Yidong Chen; Michael J Difilippantonio; Heinz Becker; B Michael Ghadimi; Thomas Ried
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

9.  Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability.

Authors:  Kishore Guda; Madhvi B Upender; Glenn Belinsky; Christopher Flynn; Masako Nakanishi; Jillian N Marino; Thomas Ried; Daniel W Rosenberg
Journal:  Oncogene       Date:  2004-05-06       Impact factor: 9.867

10.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

View more
  79 in total

1.  Targeting colorectal cancer (stem-like) cells using LGR5 directed antibody drug conjugates.

Authors:  Daniela Hirsch; Thomas Ried
Journal:  Ann Transl Med       Date:  2016-12

Review 2.  The third dimension: new developments in cell culture models for colorectal research.

Authors:  Joana F S Pereira; Nikhil T Awatade; Cláudia A Loureiro; Paulo Matos; Margarida D Amaral; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

3.  Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer.

Authors:  Guangming Chen; Chenxi Gao; Xuan Gao; Dennis Han Zhang; Shih-Fan Kuan; Timothy F Burns; Jing Hu
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

4.  Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling.

Authors:  Z-J Lei; J Wang; H-L Xiao; Y Guo; T Wang; Q Li; L Liu; X Luo; L-L Fan; L Lin; C-Y Mao; S-N Wang; Y-L Wei; C-H Lan; J Jiang; X-J Yang; P-D Liu; D-F Chen; B Wang
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

5.  LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway.

Authors:  Y U Lin; Tingyu Wu; Qianqian Yao; Shuming Zi; Long Cui; Ming Yang; Jinming Li
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

6.  MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.

Authors:  Xiaojun Yang; Jing Ye; Han Yan; Zhaoyang Tang; Jian Shen; Jianping Zhang; Lihua Yang
Journal:  Tumour Biol       Date:  2015-07-19

7.  From the Cover: PhIP/DSS-Induced Colon Carcinogenesis in CYP1A-Humanized Mice and the Possible Role of Lgr5+ Stem Cells.

Authors:  Jayson X Chen; Hong Wang; Anna Liu; Lanjing Zhang; Kenneth Reuhl; Chung S Yang
Journal:  Toxicol Sci       Date:  2016-09-23       Impact factor: 4.849

8.  TROY is a promising prognostic biomarker in patients with colorectal cancer.

Authors:  Mitsuaki Nishioka; Yutaka Suehiro; Kouhei Sakai; Toshihiko Matsumoto; Naoko Okayama; Hidekazu Mizuno; Koji Ueno; Nobuaki Suzuki; Shinichi Hashimoto; Taro Takami; Shoichi Hazama; Hiroaki Nagano; Isao Sakaida; Takahiro Yamasaki
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

9.  ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Authors:  Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey
Journal:  Carcinogenesis       Date:  2015-04-27       Impact factor: 4.944

10.  FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.

Authors:  Shubhashish Sarkar; Malaney R O'Connell; Yoshinaga Okugawa; Brian S Lee; Yuji Toiyama; Masato Kusunoki; Robert D Daboval; Ajay Goel; Pomila Singh
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.